Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2019-07-03 2019-03-27
Drug Identification Number 00649074 00649074
Brand name METRONIDAZOLE INJECTION USP METRONIDAZOLE INJECTION USP
Common or Proper name Metronidazole Injection USP Metronidazole Injection USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients METRONIDAZOLE METRONIDAZOLE
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 80 x 100mL PLBG 24 x 100mL PLBG
ATC code J01XD J01XD
ATC description OTHER ANTIBACTERIALS OTHER ANTIBACTERIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-02-01
Actual discontinuation date 2019-07-02
Remaining supply date 2020-07-02 2020-02-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments METRONIDAZOLE 5mg/mL 24x100mL PLBG remains available. METRONIDAZOLE 5mg/mL 24x100mL PLBG will remain available.
Health Canada comments